ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cristiano Amarelli
Cristiano Amarelli, M.D.
Background
Second University of Naples Medical School (M.D. 1998)
Second University of Naples Cardiac Surgery Residency (1998-2003)
Other Interests
Heart Transplantation and Immunosuppression
Perioperative Organ Preservation in complex heart surgery
Mitral Valve Repair
Mechanical prostheses performances
Surgery of Aortic dissection
Research
International Publications: · 39--> 89.21 TOTAL IMPACT
Indice H: 12, dal 2008: 11
i10-index: 18, dal 2008: 13
Research Projects
-2001 Principal subinvestigator FUJISAWA FG-506-05-02 “An open,multicentre, prospectively randomized , parallel group study comparing Tacrolimus (FK506) and Cyclosporin microemulsion
based immunosuppressive therapy in prymary orthotopic heart tranplantation”
-2002 Principal subinvestigator ROCHE M55021 “Studio, pilota, aperto, randomizzato, per gruppi paralleli volto a valutare la variabilità farmacocinetica di micofenolato mofetile somministrato in associazione con ciclosporina e corticosteroidi per 9 mesi dopo 3 mesi di terapia a dosi fisse o dosi fisse e a dosi stabilite sulle base dei livelli plasmatici in pazienti sottoposti a trapianto cardiaco ortotopico primario”
-2003 Principal subinvestigator of the retrospective clinical and echocardiographic follow-up of St.Jude Regent 17-mm prostheses (integrative data for the FDA approval)
-2004 Principal subinvestigator 3-months follow-up of porcine Epic Supra prostheses.
-2005 Principal subinvestigator NOVARTIS protocol 2310 “A Six-month,Multicenter, Randomized, Open-label Study of the Safety, Tolerability and Efficacy of Two Neoral® Doses in addition to
Certican and Steroids in de novo Heart Transplant Recipients”
-2008 Principal subinvestigator NOVARTIS protocol “CERTIC - studio osservazionale condotto in pazienti italiani trapiantati di cuore o rene in trattamento con terapia immunosoppressiva comprendente everolimus (Certican®).”
-2009 Principal subinvestigator NOVARTIS protocol EVERHEART CRAD001AIT16 “Early vs.delayed EVERolimus in de novo HEART transplant recipients: optimization of the safety/efficacy profile”
Additional Educational Information
School of Medicine Degree, Surgery, 1992– 1998
Qualification for Medical Practice with first class grades, 1999
Specialty Degree in Cardiac Surgery with first class grades and honours (Second University of Naples), discussing “Aortic valve replacement with small St Jude prostheses (17 mm) in patients with aortic stenosis: clinical and echocardiographic outcome” tutored by Prof. M. Cotrufo; 2003
Practice Areas
- Cardiac
